Literature DB >> 11488634

Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).

M Yura1, I Takahashi, M Serada, T Koshio, K Nakagami, Y Yuki, H Kiyono.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model for multiple sclerosis in humans. EAE can be passively transferred into naive syngeneic animals by administration of MOG-specific T cell clones. Lymphocytes isolated from green fluorescent protein (GFP)-transgenic (Tg) mice can light up by emitting green fluorescence, thus making it feasible to use such animals in a passive transfer model for EAE. When MOG-sensitized splenic lymphocytes from GFP-Tg mice were adoptively transferred to irradiated, syngeneic C57BL/6 and RAG-1(-/-)mice, typical symptoms of EAE developed. Analysis of the reconstituted mice with EAE revealed prominent infiltration of fluorescing (GFP+), CD4+ T cells into the central nervous system (CNS). Real-time confocal imaging revealed these cells in the spinal cords and brains of recipient mice. This infiltration was also confirmed by anti-GFP monoclonal antibodies. Furthermore, quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) evaluation indicated that the infiltrating GFP+, CD4+ T cells exclusively produced T helper type 1 (Th1) cytokines, especially interferon-gamma (IFN-gamma). These results clearly show that MOG-specific CD4+ T cells preferentially invade into the CNS and mediate the development of EAE by producing Th1-biased cytokines. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488634     DOI: 10.1006/jaut.2001.0520

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

1.  Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.

Authors:  Juhua Zhou; Prakash Nagarkatti; Yin Zhong; Mitzi Nagarkatti
Journal:  J Neuroimmunol       Date:  2010-06       Impact factor: 3.478

2.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.

Authors:  Priscilla W Lee; Alan J Smith; Yuhong Yang; Amanda J Selhorst; Yue Liu; Michael K Racke; Amy E Lovett-Racke
Journal:  JCI Insight       Date:  2017-09-07

4.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

5.  Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.

Authors:  Qi Wu; Qin Wang; Guangmei Mao; Catherine A Dowling; Steven K Lundy; Yang Mao-Draayer
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

Review 6.  Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?

Authors:  Amy E Lovett-Racke; Yuhong Yang; Michael K Racke
Journal:  Biochim Biophys Acta       Date:  2010-06-18

7.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

8.  Cannabinoids decrease the th17 inflammatory autoimmune phenotype.

Authors:  Ewa Kozela; Ana Juknat; Nathali Kaushansky; Neta Rimmerman; Avraham Ben-Nun; Zvi Vogel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-28       Impact factor: 4.147

9.  Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.

Authors:  Maria Bettini; Kristen Rosenthal; Brian D Evavold
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

10.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

Authors:  Yuhong Yang; Jeffrey Weiner; Yue Liu; Alan J Smith; David J Huss; Ryan Winger; Haiyan Peng; Petra D Cravens; Michael K Racke; Amy E Lovett-Racke
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.